Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 112 Mcg (0.0112 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton
Recall Summary Major Pharmaceuticals is recalling Levothyroxine Sodium 112 mcg tablets (NDC 0904-6954-61) distributed nationwide because the medication is subpotent, meaning it contains less active ingredient than intended. This recall affects people who received this thyroid medication in all 50 states, Washington DC, and U.S. territories.
- Recalling firm
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6954-61
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/9dcadf57-72f9-46c7-8413-1d620a1c76fc